Liberals latest attempt to lower drug prices undermines America’s IP System – and violates the intent of the longstanding bipartisan law that enables universities, nonprofit research institutions and small businesses …
Congress just voted on the “Inflation Reduction Act,” the latest version of Democrats’ signature Build Back Better legislation. This misguided legislation will harm patients, taxpayers, and the economy. The Inflation Reduction Act …
As Congress prepares to vote on President Biden’s tax-and-spend bill, we are pleased to unveil the results of a national poll commissioned by CIFE, taken in the past week by …
Today CIFE is launching a one week national paid TV and digital campaign to educate and activate the public to stop President Biden’s reckless tax-and-spend bill that’s currently being considered …
Unfortunately, drug importation is being considered for inclusion in the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. While the Center for Innovation and Free Enterprise supports swift …
The overall cost of healthcare continues to cripple America’s businesses and employees. Fortunately, Congress passed the No Surprises Act (NSA), which establishes new federal protections for patients against surprise medical …
It’s World IP Day! This year’s theme is “IP for a Better Future: Young Innovators” Today we acknowledge the benefits intellectual property brings to America currently and we continue to …
The American people are talking but lawmakers are not listening. Americans do not support big government imposing price settings on prescription drugs. In fact, voters support less government involvement, especially …
Intellectual property is paving the way for a promising future – saving lives through investing millions in research to discover and create multiple COVID-19 vaccines. The development of multiple coronavirus …
